Quarterly report pursuant to Section 13 or 15(d)

PROPERTY AND EQUIPMENT, NET

v3.21.1
PROPERTY AND EQUIPMENT, NET
3 Months Ended
Mar. 31, 2021
Property, Plant and Equipment [Abstract]  
PROPERTY AND EQUIPMENT, NET

NOTE 3 – PROPERTY AND EQUIPMENT, NET

 

Property and equipment, net consisted of the following (in thousands):

 

    March 31     December 31  
    2021     2020  
    (in thousands)  
Land   $ 5,713     $ 5,713  
Construction in progress     3,290       2,800  
Office furniture and equipment     400       385  
Leasehold improvements     23       23  
      9,426       8,921  
Less: Accumulated depreciation and amortization     (356 )     (350 )
    $ 9,070     $ 8,571  

  

On September 28, 2020, the Company completed the purchase of its 40,000 square foot facility in Massachusetts for $4,000,000, to house its new Advanced Development Center for accelerated development and manufacturing of vaccines. Of the total purchase price, $1.2 million was allocated to the value of land acquired, and $2.8 million was allocated to construction in progress, as the building was not ready for its intended use. As of March 31, 2021, the asset has not been placed in service.

 

On December 23, 2020, the Company completed the purchase of its approximately 44-acre site in Hamilton, Montana for $4.4 million, for the construction of a vaccine development and commercial scale manufacturing facility. As of March 31, 2021, the asset has not been placed in service.